MOTS-c
MetabolicMitochondrial-derived metabolic research peptide.
Description
MOTS-c is a mitochondrial-derived peptide, supplied as a lyophilized powder for in-vitro research. It is studied in laboratory models of metabolic regulation, insulin sensitivity, and exercise/mitochondrial signaling. Sold strictly for research use, not for human or veterinary use.
Storage & handling
Store lyophilized vials at -20 °C, protected from light and moisture. Keep sealed until use and avoid repeated freeze–thaw cycles. Handle per your laboratory's standard operating procedures.
Research applications
- Metabolic-regulation and insulin-sensitivity research
- Mitochondrial-signaling pathway studies
- Exercise-physiology research models
Sold strictly for in-vitro laboratory research. Not for human or veterinary use, diagnosis, treatment, or consumption.
Research status
Where the published evidence stands for each active compound, with the primary source. Regulatory standing is listed for context only. Nothing sold here is approved for human use.
- MOTS-cEarly clinical
First described in 2015 and still characterized mainly in cell and animal models. Early human work on a MOTS-c analog has been registered for metabolic and cardiovascular indications.
PMC9905433 · MOTS-c therapeutic review
Researchers also viewed
“Purity matched the label exactly. Mass spec and HPLC both checked out. Reordering.”
Research associate, Raleigh, NC